Irritant (e.g., Tear Gas, Etc.) Patents (Class 514/890)
  • Patent number: 9604891
    Abstract: As shown by the following reaction formula, disclosed is a fluorine-containing hydroxyaldehyde production method, including the step of obtaining a fluorine-containing hydroxyaldehyde represented by the general formula (1) by reacting a fluorine-containing ketone represented by the general formula (4) and an aldehyde represented by the general formula (5) in the presence of an organic base selected from a heterocyclic compound which contains a nitrogen atom in its ring or a tertiary amine. By this production method, it is possible to obtain the fluorine-containing hydroxyaldehyde in a high yield. Furthermore, it is possible to easily obtain in high yields a fluorine-containing propanediol, which is a derivative of this fluorine-containing hydroxyaldehyde, and a fluorine-containing alcohol monomer by using the same.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: March 28, 2017
    Assignee: Central Glass Company, Limited
    Inventors: Hitoshi Oomuro, Ryo Nadano, Masafumi Hirotsu
  • Patent number: 7544781
    Abstract: A process for producing a polypeptide, by reacting a peptide component (A) represented by formula (1) below with a peptide component (B) represented by formula (2) below and optionally a compound (C) represented by formula (3) below, to obtain said polypeptide: (1) X-(Pro-Y-Gly)n-OH, wherein: X represents H or the group HOOC—(CH2)m—CO— and m denotes an integer of 1 to 18, Y represents Pro or Hyp, and n denotes an integer of 1 to 20; (2) X-(Z)r—OH, wherein X represents H or the group HOOC—(CH2)m—CO— and m denotes an integer of 1 to 18, Z represents a peptide chain comprising 1 to 10 amino acid residue(s), and r denotes an integer of 1 to 20; and (3) H2N—R—NH2, wherein R represents a linear or branched alkylene group; and further wherein the ratio of the peptide component (A) relative to the peptide component (B) is 100/0 to 30/70 (mol %); provided that in the case where X represents the group HOOC—(CH2)m—CO— and m has the same meaning as defined above in formula (1) and/or (2), the amount of compou
    Type: Grant
    Filed: July 26, 2007
    Date of Patent: June 9, 2009
    Assignee: PHG Corporation
    Inventors: Masao Tanihara, Chikara Otsuki, Hiroshi Mikami, Hisao Kinoshita
  • Patent number: 7262275
    Abstract: The invention provides for a polypeptide, which is useful as a biomaterial and free from infection. The polypeptide comprises a peptide unit of formula (1), and optionally one or more units of formulae (2) to (3): (1) [—(OC—(CH2)m—CO)p-(Pro-Y-Gly)n-]a; (2) [—(OC—(CH2)m—CO)q-(Z)r-]b; and (3) [—HN—R—NH—]c, wherein “m” is 1-18 , “p” and “q” are identical or different, and each is 0 or 1 , “Y” is Pro or Hyp, and “n”1-20 ; “Z” is a peptide chain comprising 1-10 amino acids, “r”1-20 , and “R” is a linear or branched alkylene group; the molar ratio of “a” to “b”[a/b] is 100/0 to 30/70 ; when p=1 and q=0, c=a, when p=0 and q=1, c=b, when p=1 and q=1, c=a+b, and when p=0 and q=0, c=0; and the polypeptide shows a peak of molecular weight in a range from 1×104 to 100×104 in the molecular weight distribution.
    Type: Grant
    Filed: February 26, 2003
    Date of Patent: August 28, 2007
    Assignee: PHG Corporation
    Inventors: Masao Tanihara, Chikara Otsuki, Hiroshi Mikami, Hisao Kinoshita
  • Patent number: 5217708
    Abstract: The present invention provides a capsicum containing lachrymator. The lachrymator comprises a nonflammable carrier and capsicum. The nonflammable carrier comprises propylene glycol, ethyl alcohol and water. In one preferred embodiment the lachrymator comprises about 0.3 percent by weight capsicum, about 14.7 percent by weight propylene glycol, about 35 percent by weight ethyl alcohol and about 50 percent by weight water.
    Type: Grant
    Filed: February 5, 1992
    Date of Patent: June 8, 1993
    Assignee: Defense Technology Corporation of America
    Inventor: Barry D. Pinkney
  • Patent number: 5026545
    Abstract: A pharmaceutical composition comprises an immune complex of an allergen and a purified antibody specific thereto, the allergen being selected from a specific subclass of antigen which causes immediate hypersensitivity that is mediated by IgE antibody, and a pharmacologically acceptable carrier or diluent. The method of using the compositions in the treatment of immediate hypersensitivity to the allergen is also described.
    Type: Grant
    Filed: September 20, 1989
    Date of Patent: June 25, 1991
    Assignees: Baxter International, Inc., International Institute of Cellular and Molecular Pathology
    Inventors: Jean-Marie Saint-Remy, Philippe Lebrun, Serge Lebeque, Pierre L. Masson
  • Patent number: 5000347
    Abstract: A method for dispensing a protective fluid is set forth wherein a container is provided formed with a transparent storage portion threadedly receiving a cap thereto. The cap includes a lower end formed with a series of alignment bores for receiving tubular projections integrally formed coaxially upon an exterior surface of the portion of the cap to enable reciprocation of the upper portion relative to the lower portion. Positioning rods are positioned adjacent each of the bores to provide an abutment to enable effective alignment of the projections with the bores. The container is filled with a lemon juice concentrate, whereupon the container is prepared for transport by an individual. The upper portion of the cap may be rotated relative to the lower portion of the cap to permit reciprocation and projection of the lemon juice spray upon an attacker imposing oneself upon an individual.
    Type: Grant
    Filed: July 24, 1989
    Date of Patent: March 19, 1991
    Inventor: Anh T. H. Tran
  • Patent number: 4740371
    Abstract: In the treatment of allergy, desensitization is effected by administering the allergen in admixture with an antibody thereto, the antibody being present in a molar excess. The antibody is preferably one raised in the patient.
    Type: Grant
    Filed: September 17, 1984
    Date of Patent: April 26, 1988
    Assignee: International Institute of Cellular and Molecular Pathology
    Inventors: Jean-Marie St. Remy, Philippe Lebrun, Serge Lebecque, Pierre Masson
  • Patent number: 4672122
    Abstract: New chemical compounds having the generic formula: ##STR1## wherein X is one equivalent of a monovalent or polyvalent anion; R and R' re methyl or ethyl radicals; R.sub.1, R.sub.1 ', R.sub.2, R.sub.2 ' are hydrogen or a methyl radical; and Z is a radical selected from methyl, ethyl, propyl, butyl, or pentyl and having utility as incapacitating agents and in munitions.
    Type: Grant
    Filed: January 21, 1972
    Date of Patent: June 9, 1987
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Harold Z. Sommer, George E. Wicks, Jr.
  • Patent number: 4672123
    Abstract: New chemical compounds having the generic formula: ##STR1## wherein X is one equivalent of an anion selected from monovalent and pollent anions, and R,R' and Z are aliphatic radicals selected from the group consisting of ethyl, propyl, and butyl, with the provision that when Z is a radical selected from the group of octyl, dodecyl, and cyclohexyl, R,R' are selected from methyl and ethyl groups, and having utility as incapacitating agents and in munitions.
    Type: Grant
    Filed: April 28, 1967
    Date of Patent: June 9, 1987
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Harold Z. Sommer, George E. Wicks, Jr.
  • Patent number: 4598096
    Abstract: A method of safely forcing the egress of human beings from a zone by supplying the zone with an irritating amount of 1-methoxy-1,3,5-cycloheptatriene.
    Type: Grant
    Filed: November 6, 1981
    Date of Patent: July 1, 1986
    Inventor: George A. Grant